SPONSOR
Henry Ford Health System
Total Trials
9
Recruiting
9
Phases
Phase 1, Phase 2
Conditions studied: To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue PerfusionInsomniaNightmares Associated With Trauma and StressNightmaresPTSD - Post Traumatic Stress DisorderKidney CancersHematological MalignancySuicide PreventionAlcohol-related Liver DiseaseLiver Diseases
Henry Ford Health System is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion, Insomnia, Nightmares Associated With Trauma and Stress, Nightmares.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Henry Ford Health System
How many clinical trials has Henry Ford Health System sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Henry Ford Health System, of which 9 are actively recruiting participants. These trials cover conditions including To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion, Insomnia, Nightmares Associated With Trauma and Stress. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Henry Ford Health System research focus on?
Henry Ford Health System clinical trials span To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion, Insomnia, Nightmares Associated With Trauma and Stress, Nightmares, PTSD - Post Traumatic Stress Disorder, and additional conditions. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Henry Ford Health System clinical trial?
To participate in a Henry Ford Health System trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Henry Ford Health System trials with current recruitment status updated daily.
Clinical Trials by Henry Ford Health System
NCT07793266 Phase 1
Recruiting
ICG Fluorescence in Knee Arthroscopy Study
To Assess the Feasibility, Visualization Capability, and Optimal Dosing of ICG Fluorescence Imaging for Intraoperative Assessment of Knee Tissue Perfusion
NCT07121270
Recruiting
Restorative Early Sleep Treatment After the Emergency Department
Insomnia
NCT07828704 Phase 2
Recruiting
Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
Kidney Cancers
NCT03850366 Phase 2
Recruiting
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib
Hematological Malignancy
NCT06506344
Recruiting
Syncing Screening and Services for Suicide Prevention Across Health and Jail Systems
Suicide Prevention
NCT06269510
Recruiting
Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients
Alcohol-related Liver Disease
NCT06070428
Recruiting
Project 4: ACHIEVE PATHFINDER
Heart Failure
NCT05426928
Recruiting
Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC
HIPEC
NCT05023772
Recruiting
Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases
Neoplasm Metastasis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology